The Centers for Disease Control and Prevention yesterday released recommendations for the ethical allocation of COVID-19 vaccines, once available to the public.

CDC’s Advisory Committee on Immunization Practices identified four ethical principles on which to base allocation recommendations while supplies of COVID-19 vaccines are limited — maximizing benefits and minimizing harms, promoting justice, mitigating health inequities, and promoting transparency.

The committee notes that such consideration must be viewed in the context of science (e.g., available information about the vaccines’ characteristics, including safety and efficacy in older adults and epidemiologic risk) and feasibility of implementation (e.g., storage and handling requirements).

Related News Articles

Headline
The public health emergency will likely remain in place through 2021, and the administration will give states 60 days’ notice before it decides to terminate…
Headline
The Food and Drug Administration Jan. 21 reissued emergency use authorizations for 10 systems authorized to decontaminate certain N95 respirators used by…
Headline
Pfizer Inc. has completed enrolling children aged 12 to 15 in a COVID-19 vaccine study, the drug maker confirmed Friday.  Pfizer said the Phase 3…
Chairperson's File
This year, I look forward to continuing AHA’s Leadership Rounds, short conversations on trending topics with health care leaders from around the country.…
Headline
As COVID-19 surges continue, lessons learned by health systems large and small reveal the importance of teamwork, communication, flexibility, preparation and…
Headline
The Centers for Disease Control and Prevention today reported 10 cases of anaphylaxis, a life-threatening allergic reaction, among the more than 4 million…